The rise of buprenorphine prescribing in England: analysis of NHS regional data, 2001-03.
AIMS: Since its launch in the prescribing market in 1999 for the treatment of opiate dependence, buprenorphine has rapidly become established as an alternative to methadone treatment in the United Kingdom. In the absence of evidence of its clinical superiority over methadone, and given its high rela...
| Publicado en: | Addiction Vol. 100; no. 4; pp. 495 - 500 |
|---|---|
| Autores principales: | , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Apr2005
|
| Acceso en línea: | Ver este registro en EBSCOhost |